Your session is about to expire
← Back to Search
Long-Term Follow-Up for Prostate Cancer
N/A
Waitlist Available
Led By Saro Armenian, DO
Research Sponsored by City of Hope Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
No history of recurrent, progressive, or metastatic disease
No history of other urologic cancer (e.g., bladder cancer, renal cell carcinoma) in addition to prostate cancer
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 10 years
Awards & highlights
Study Summary
This trial looks at how well patients with prostate cancer do after surgery, in the long term. The data may help answer clinical questions, and help with future studies on how to improve the quality of life for prostate cancer survivors.
Who is the study for?
This trial is for prostate cancer survivors who had surgery at least a year ago, are currently free of cancer or have stable disease, and haven't had radiation or chemo for prostate cancer. Men with other urologic cancers or those on hormone therapies can't join.Check my eligibility
What is being tested?
The study looks at the effectiveness of long-term follow-up care in men after prostate cancer surgery. It includes educational materials, regular questionnaires, lab tests to check health markers, and assessments of life quality over time.See study design
What are the potential side effects?
Since this trial involves non-invasive procedures like follow-ups and questionnaires rather than medication or invasive treatments, there are no direct side effects associated with the interventions being studied.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My cancer has not come back or spread after treatment.
Select...
I have prostate cancer and no history of other urologic cancers.
Select...
I have been diagnosed with prostate cancer.
Select...
I have not had radiation or chemotherapy for prostate cancer.
Select...
My cancer is not growing or has no signs of being present.
Select...
I had surgery at City of Hope.
Select...
It has been over a year since my prostate cancer surgery.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 10 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 10 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
HRQL assessed using Expanded Prostate Cancer Index Composite
HRQL assessed using Sexual Health Inventory for Men
Incidence rates of the study end-points
Trial Design
1Treatment groups
Experimental Treatment
Group I: Supportive Care (long-term follow-up)Experimental Treatment5 Interventions
Patients undergo long-term follow-up and receive a written survivorship care plan including comprehensive health evaluation and health education beginning 1 year post surgery.
Find a Location
Who is running the clinical trial?
City of Hope Medical CenterLead Sponsor
569 Previous Clinical Trials
1,922,188 Total Patients Enrolled
15 Trials studying Cancer Survivors
1,401 Patients Enrolled for Cancer Survivors
National Cancer Institute (NCI)NIH
13,687 Previous Clinical Trials
40,927,871 Total Patients Enrolled
70 Trials studying Cancer Survivors
14,962 Patients Enrolled for Cancer Survivors
Saro Armenian, DOPrincipal InvestigatorCity of Hope Medical Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My cancer has not come back or spread after treatment.I have prostate cancer and no history of other urologic cancers.I have been diagnosed with prostate cancer.I have not had radiation or chemotherapy for prostate cancer.I am currently on testosterone replacement or androgen deprivation therapy.My cancer is not growing or has no signs of being present.I had surgery at City of Hope.It has been over a year since my prostate cancer surgery.
Research Study Groups:
This trial has the following groups:- Group 1: Supportive Care (long-term follow-up)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there still availability for enrolling in this research trial?
"The clinicaltrials.gov website reveals that this particular medical trial, which was first listed on July 23rd 2008, is currently not enrolling patients. Despite the lack of open availability for this study, 1351 other studies are presently accepting participants."
Answered by AI
Share this study with friends
Copy Link
Messenger